A decision on the matter is not expected for at least another week.
The US Food and Drug Administration (FDA) will meet this week to decide whether Moderna, Inc. and to whom and when should additional doses of Johnson & Johnson Jensen COVID-19 vaccines be distributed?
Agency advisors will give their recommendation on the matter before the FDA makes an official decision on booster shot authorization — which has already been the subject of some disagreement.
Fully vaccinated and had COVID-19? No rush for a booster shot, say experts:
A reply is not expected for at least another week and a US Centers for Disease Control and Prevention (CDC) panel next week see you for details, with its decision subject to approval by the CDC Director. Rochelle Valensky.
In September, a CDC advisory panel OK Booster for Pfizer’s Vaccine At the six-month point for individuals 65 years of age and older, individuals aged 18 to 64 who are at “high risk of severe COVID-19” and residents of nursing homes.
valensky dismissed his advisors, adding that lakhs of people working in high-risk places should be added to the list.
Now, the FDA will reportedly weigh whether Moderna Booster should contain half of the original dose, what is the best time for a second shot of the single-dose Johnson & Johnson vaccine, and the potential effectiveness and safety of using multiple brands of vaccines. check. .
While all three vaccines still provide strong protection against death from the virus and COVID-19, White House officials announced in August – Amid the outbreak of the Delta variant – the booster will be offered to almost all adults.
However, many have argued that little is known about breakthrough infections and whether boosters will be necessary for people who have already been fully vaccinated.
CDC data shows that more than 103 million Americans are fully vaccinated with Pfizer’s vaccine, 69 million with Moderna and 15 million with Johnson & Johnson.
In total, more than 187.2 million people have been fully vaccinated and about 7.8 million people Booster dose has been received.
Federal regulators meet because vaccinations have increased by more than 50% in the past few weeks due to employer vaccine mandates and Pfizer boosters.
Get Granthshala Business on the go by clicking here
Members of the public who wish to submit data, information or ideas to the FDA Committee This can be done electronically or by mail..
A docket — under the number FDA-2021-N-0965 — was installed and will close on Wednesday. Comments received before Tuesday will be provided to the committee, while those after Tuesday and by Wednesday will be considered by the FDA.